30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
IE Insurance

Willis Towers Watson PLC (WTW)

Track

In the last 90 days, Willis Towers Watson PLC saw two executive buy transactions totaling over $1 million. Notably, the CEO and President of Risk & Broking made significant purchases. This activity occurred against a backdrop of a 10.3% stock price decrease over the same period. The company's last earnings report showed a slight beat.
Stock chart
Ticker: WTW Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Clarke Lucy
President of Risk & Broking
1 purchase — total 499,340 USD
Buy 6 May 2026
Value US$4,339,523.57 | Price 117.15 | Shares 85,115
Buy 4 May 2026
Value US$2,200,517.66 | Price 173.31 | Shares 75,986
Sale 3 Mar 2026
Value US$912,008.70 | Price 304.00 | Shares 3,000
Proposed sale 3 Mar 2026
Value US$912,008.72 | Price 304.00 | Shares 3,000
Buy 13 Feb 2026
Value US$996,928.80 | Price 284.84 | Shares 3,500
Buy 12 Feb 2026
Value US$67,205.26 | Price 278.86 | Shares 241
Planned sale 3 Jun 2025
Value US$505,200.00 | Price 315.75 | Shares 1,600
Proposed sale 3 Jun 2025
Value US$505,200.00 | Price 315.75 | Shares 1,600
Planned sale 8 May 2025
Value US$81,333.80 | Price 306.92 | Shares 265
Proposed sale 8 May 2025
Value US$81,333.80 | Price 306.92 | Shares 265
Planned sale 8 May 2025
Value US$220,314.23 | Price 310.74 | Shares 709
Planned sale 8 May 2025
Value US$895,255.97 | Price 309.67 | Shares 2,891
Planned sale 8 May 2025
Value US$1,871,826.78 | Price 308.78 | Shares 6,062
Planned sale 8 May 2025
Value US$59,118.34 | Price 307.91 | Shares 192
Planned sale 8 May 2025
Value US$44,800.20 | Price 306.85 | Shares 146
Proposed sale 8 May 2025
Value US$3,091,315.69 | Price 309.13 | Shares 10,000
Sale 3 Mar 2025
Value US$547,404.81 | Price 338.74 | Shares 1,616
Proposed sale 3 Mar 2025
Value US$547,318.03 | Price 338.69 | Shares 1,616
Proposed sale 28 Feb 2025
Value US$1,136,069.62 | Price 335.72 | Shares 3,384
Sale 28 Feb 2025
Value US$1,136,243.31 | Price 335.77 | Shares 3,384
Sale 1 Mar 2024
Value US$299,345.86 | Price 272.13 | Shares 1,100
Proposed sale 1 Mar 2024
Value US$299,345.86 | Price 272.13 | Shares 1,100
Sale 20 Feb 2024
Value US$1,380,144.50 | Price 276.03 | Shares 5,000
Proposed sale 20 Feb 2024
Value US$1,379,876.56 | Price 275.98 | Shares 5,000
Sale 8 Feb 2024
Value US$1,460,214.00 | Price 270.41 | Shares 5,400
Proposed sale 8 Feb 2024
Value US$1,460,214.00 | Price 270.41 | Shares 5,400
Sale 9 Nov 2023
Value US$78,827.50 | Price 238.87 | Shares 330
Planned sale 3 Jul 2023
Value US$207,129.60 | Price 230.14 | Shares 900
Planned sale 3 Jul 2023
Value US$138,844.50 | Price 231.41 | Shares 600
Planned sale 3 Jul 2023
Value US$117,410.00 | Price 234.82 | Shares 500
Proposed sale 3 Jul 2023
Value US$463,193.40 | Price 231.60 | Shares 2,000
Sale 7 Jun 2023
Value US$1,122,230.00 | Price 224.45 | Shares 5,000
Proposed sale 7 Jun 2023
Value US$1,122,058.52 | Price 224.41 | Shares 5,000
Proposed sale 1 Jun 2023
Value US$545,631.63 | Price 218.25 | Shares 2,500
Planned sale 1 Jun 2023
Value US$545,868.00 | Price 218.35 | Shares 2,500
Planned sale 1 May 2023
Value US$578,589.50 | Price 231.44 | Shares 2,500
Proposed sale 1 May 2023
Value US$596,200.00 | Price 238.48 | Shares 2,500
Planned sale 3 Apr 2023
Value US$580,940.75 | Price 232.38 | Shares 2,500
Proposed sale 3 Apr 2023
Value US$580,729.14 | Price 232.29 | Shares 2,500
Planned sale 1 Mar 2023
Value US$328,300.27 | Price 233.83 | Shares 1,404
Planned sale 1 Mar 2023
Value US$255,214.12 | Price 232.86 | Shares 1,096
Planned sale 14 Feb 2023
Value US$336,783.06 | Price 247.63 | Shares 1,360
Planned sale 14 Feb 2023
Value US$49,276.00 | Price 246.38 | Shares 200
Planned sale 14 Feb 2023
Value US$354,043.87 | Price 245.86 | Shares 1,440
Planned sale 9 Feb 2023
Value US$87,295.98 | Price 249.42 | Shares 350
Planned sale 9 Feb 2023
Value US$295,576.78 | Price 250.28 | Shares 1,181
Planned sale 9 Feb 2023
Value US$50,353.00 | Price 251.77 | Shares 200
Planned sale 9 Feb 2023
Value US$203,098.00 | Price 253.87 | Shares 800
Planned sale 9 Feb 2023
Value US$178,507.00 | Price 255.01 | Shares 700
Planned sale 9 Feb 2023
Value US$120,744.50 | Price 256.90 | Shares 470
Planned sale 9 Feb 2023
Value US$334,140.21 | Price 257.23 | Shares 1,299
Sale 21 Nov 2022
Value US$1,175,374.50 | Price 235.07 | Shares 5,000
Sale 18 Nov 2022
Value US$1,906,320.00 | Price 235.00 | Shares 8,112
Sale 9 Nov 2022
Value US$1,470,245.66 | Price 225.50 | Shares 6,520
Planned sale 1 Nov 2022
Value US$306,704.02 | Price 219.07 | Shares 1,400
Planned sale 31 Oct 2022
Value US$22,314.53 | Price 218.77 | Shares 102
Planned sale 31 Oct 2022
Value US$414,374.21 | Price 218.32 | Shares 1,898
Planned sale 4 Oct 2022
Value US$294,000.00 | Price 210.00 | Shares 1,400
Sale 7 Sep 2022
Value US$414,473.50 | Price 209.86 | Shares 1,975
Sale 7 Sep 2022
Value US$357,208.80 | Price 208.65 | Shares 1,712
Sale 7 Sep 2022
Value US$857,472.64 | Price 207.52 | Shares 4,132
Sale 7 Sep 2022
Value US$718,382.97 | Price 206.61 | Shares 3,477
Sale 7 Sep 2022
Value US$541,258.52 | Price 205.88 | Shares 2,629
Sale 7 Sep 2022
Value US$216,569.96 | Price 210.26 | Shares 1,030
Planned sale 2 Sep 2022
Value US$294,002.94 | Price 210.00 | Shares 1,400
Sale 26 Aug 2022
Value US$2,094,700.00 | Price 209.47 | Shares 10,000
Sale 18 Aug 2022
Value US$4,947,140.00 | Price 220.00 | Shares 22,487
Sale 17 Aug 2022
Value US$87,560.00 | Price 220.00 | Shares 398
Sale 16 Aug 2022
Value US$242,018.48 | Price 220.02 | Shares 1,100
Planned sale 4 Aug 2022
Value US$294,014.00 | Price 210.01 | Shares 1,400
Planned sale 1 Jun 2022
Value US$294,938.00 | Price 210.67 | Shares 1,400
Planned sale 2 May 2022
Value US$20,949.85 | Price 215.98 | Shares 97
Planned sale 2 May 2022
Value US$64,350.39 | Price 214.50 | Shares 300
Planned sale 2 May 2022
Value US$86,088.13 | Price 213.62 | Shares 403
Planned sale 2 May 2022
Value US$254,755.44 | Price 212.30 | Shares 1,200
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-06 2026-05-06 B Purchase
Clarke Lucy

President of Risk & Broking

Officer
85,115 +23.9%
117.15
US$4,339,524 		85,115 +23.9% 117.15 US$4,339,524
2026-05-05 2026-05-04 B Purchase
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
75,986 -18.2%
173.31
US$2,200,518 		75,986 -18.2% 173.31 US$2,200,518
2026-03-05 2026-03-03 S Sale
Furman Matthew

General Counsel

Officer
69,645 -20.4%
207.03
US$2,763,550 		69,645 -20.4% 207.03 US$2,763,550
2026-03-03 2026-03-03 PrS Proposed sale
Furman Matthew

Officer

Officer
3,000
304.00
US$912,009 		3,000 304.00 US$912,009
2026-02-17 2026-02-13 B Purchase
Clarke Lucy

President of Risk & Broking

Officer
3,500 +22.2%
284.84
US$996,929 		3,500 +22.2% 284.84 US$996,929
2026-02-13 2026-02-12 B Purchase
1.6
Hammond Michael P.
Non-Executive Director
241 +10.6%
278.86
US$67,205 		241 +10.6% 278.86 US$67,205
2025-06-05 2025-06-03 PlS Planned sale
2.3
Krasner Andrew Jay

Chief Financial Officer

Officer
1,600 -11.8%
315.75
US$505,200 		1,600 -11.8% 315.75 US$505,200
2025-06-03 2025-06-03 PrS Proposed sale
2.3
Krasner Andrew Jay

Officer

Officer
1,600
315.75
US$505,200 		1,600 315.75 US$505,200
2025-05-12 2025-05-08 PlS Planned sale
Faber Alexis

Chief Operating Officer

Officer
265 -3.2%
306.92
US$81,334 		265 -3.2% 306.92 US$81,334
2025-05-12 2025-05-08 PlS Planned sale
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
709 -0.8%
310.74
US$220,314 		709 -0.8% 310.74 US$220,314
2025-05-12 2025-05-08 PlS Planned sale
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
2,891 -3.2%
309.67
US$895,256 		2,891 -3.2% 309.67 US$895,256
2025-05-12 2025-05-08 PlS Planned sale
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
6,062 -6.3%
308.78
US$1,871,827 		6,062 -6.3% 308.78 US$1,871,827
2025-05-12 2025-05-08 PlS Planned sale
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
192 -0.2%
307.91
US$59,118 		192 -0.2% 307.91 US$59,118
2025-05-12 2025-05-08 PlS Planned sale
2.5
Hess Carl Aaron

Chief Executive Officer

Executive Director
146 -0.2%
306.85
US$44,800 		146 -0.2% 306.85 US$44,800
2025-05-08 2025-05-08 PrS Proposed sale
2.5
Hess Carl Aaron

Officer; Director

Executive Director
10,000
309.13
US$3,091,316 		10,000 309.13 US$3,091,316
2025-05-08 2025-05-08 PrS Proposed sale
Faber Alexis

Officer

Officer
265
306.92
US$81,334 		265 306.92 US$81,334
2025-03-04 2025-03-03 S Sale
3.1
Gebauer Julie Jarecke

Pres.-Health, Wealth & Career

Officer
1,616 -2.2%
338.74
US$547,405 		1,616 -2.2% 338.74 US$547,405
2025-03-03 2025-03-03 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
1,616
338.69
US$547,318 		1,616 338.69 US$547,318
2025-02-28 2025-02-28 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
3,384
335.72
US$1,136,070 		3,384 335.72 US$1,136,070
2025-02-28 2025-02-28 S Sale
3.1
Gebauer Julie Jarecke

Pres.-Health, Wealth & Career

Officer
3,384 -4.3%
335.77
US$1,136,243 		3,384 -4.3% 335.77 US$1,136,243
2024-03-05 2024-03-01 S Sale
2.3
Krasner Andrew Jay

Chief Financial Officer

Officer
1,100 -20.9%
272.13
US$299,346 		1,100 -20.9% 272.13 US$299,346
2024-03-01 2024-03-01 PrS Proposed sale
2.3
Krasner Andrew Jay

Officer

Officer
1,100
272.13
US$299,346 		1,100 272.13 US$299,346
2024-02-22 2024-02-20 S Sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
5,000 -6.8%
276.03
US$1,380,144 		5,000 -6.8% 276.03 US$1,380,144
2024-02-20 2024-02-20 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
5,000
275.98
US$1,379,877 		5,000 275.98 US$1,379,877
2024-02-12 2024-02-08 S Sale
3.0
Garrard Adam

Head of Risk & Broking

Officer
5,400 -32.4%
270.41
US$1,460,214 		5,400 -32.4% 270.41 US$1,460,214
2024-02-08 2024-02-08 PrS Proposed sale
3.0
Garrard Adam

Officer

Officer
5,400
270.41
US$1,460,214 		5,400 270.41 US$1,460,214
2023-11-13 2023-11-09 S Sale
0.8
Thomson-Hall Pamela

Head of International

Officer
330 -9.0%
238.87
US$78,827 		330 -9.0% 238.87 US$78,827
2023-07-05 2023-07-03 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
900 -1.2%
230.14
US$207,130 		900 -1.2% 230.14 US$207,130
2023-07-05 2023-07-03 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
600 -0.8%
231.41
US$138,844 		600 -0.8% 231.41 US$138,844
2023-07-05 2023-07-03 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
500 -0.6%
234.82
US$117,410 		500 -0.6% 234.82 US$117,410
2023-07-03 2023-07-03 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
2,000
231.60
US$463,193 		2,000 231.60 US$463,193
2023-06-09 2023-06-07 S Sale
2.2
Pullum Anne

Head of Europe

Officer
5,000 -28.1%
224.45
US$1,122,230 		5,000 -28.1% 224.45 US$1,122,230
2023-06-07 2023-06-07 PrS Proposed sale
2.2
Pullum Anne

Officer

Officer
5,000
224.41
US$1,122,059 		5,000 224.41 US$1,122,059
2023-06-01 2023-06-01 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
2,500
218.25
US$545,632 		2,500 218.25 US$545,632
2023-06-01 2023-06-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
2,500 -3.1%
218.35
US$545,868 		2,500 -3.1% 218.35 US$545,868
2023-05-02 2023-05-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
2,500 -3.0%
231.44
US$578,590 		2,500 -3.0% 231.44 US$578,590
2023-05-01 2023-05-01 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
2,500
238.48
US$596,200 		2,500 238.48 US$596,200
2023-04-04 2023-04-03 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
2,500 -2.9%
232.38
US$580,941 		2,500 -2.9% 232.38 US$580,941
2023-04-03 2023-04-03 PrS Proposed sale
3.1
Gebauer Julie Jarecke

Officer

Officer
2,500
232.29
US$580,729 		2,500 232.29 US$580,729
2023-03-02 2023-03-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,404 -1.7%
233.83
US$328,300 		1,404 -1.7% 233.83 US$328,300
2023-03-02 2023-03-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,096 -1.3%
232.86
US$255,214 		1,096 -1.3% 232.86 US$255,214
2023-02-15 2023-02-14 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,360 -1.6%
247.63
US$336,783 		1,360 -1.6% 247.63 US$336,783
2023-02-15 2023-02-14 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
200 -0.2%
246.38
US$49,276 		200 -0.2% 246.38 US$49,276
2023-02-15 2023-02-14 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,440 -1.6%
245.86
US$354,044 		1,440 -1.6% 245.86 US$354,044
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
350 -3.7%
249.42
US$87,296 		350 -3.7% 249.42 US$87,296
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
1,181 -11.0%
250.28
US$295,577 		1,181 -11.0% 250.28 US$295,577
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
200 -1.8%
251.77
US$50,353 		200 -1.8% 251.77 US$50,353
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
800 -6.8%
253.87
US$203,098 		800 -6.8% 253.87 US$203,098
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
700 -5.6%
255.01
US$178,507 		700 -5.6% 255.01 US$178,507
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
470 -3.7%
256.90
US$120,745 		470 -3.7% 256.90 US$120,745
2023-02-10 2023-02-09 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
1,299 -9.2%
257.23
US$334,140 		1,299 -9.2% 257.23 US$334,140
2022-11-22 2022-11-21 S Sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
5,000 -5.7%
235.07
US$1,175,374 		5,000 -5.7% 235.07 US$1,175,374
2022-11-22 2022-11-18 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
8,112 -11.6%
235.00
US$1,906,320 		8,112 -11.6% 235.00 US$1,906,320
2022-11-10 2022-11-09 S Sale
0.8
ONEILL BRENDAN R
Non-Executive Director
6,520 -46.5%
225.50
US$1,470,246 		6,520 -46.5% 225.50 US$1,470,246
2022-11-02 2022-11-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,400 -1.6%
219.07
US$306,704 		1,400 -1.6% 219.07 US$306,704
2022-11-02 2022-10-31 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
102 -0.9%
218.77
US$22,315 		102 -0.9% 218.77 US$22,315
2022-11-02 2022-10-31 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
1,898 -14.9%
218.32
US$414,374 		1,898 -14.9% 218.32 US$414,374
2022-10-05 2022-10-04 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,400 -1.5%
210.00
US$294,000 		1,400 -1.5% 210.00 US$294,000
2022-09-09 2022-09-07 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
1,975 -2.7%
209.86
US$414,474 		1,975 -2.7% 209.86 US$414,474
2022-09-09 2022-09-07 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
1,712 -2.2%
208.65
US$357,209 		1,712 -2.2% 208.65 US$357,209
2022-09-09 2022-09-07 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
4,132 -5.1%
207.52
US$857,473 		4,132 -5.1% 207.52 US$857,473
2022-09-09 2022-09-07 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
3,477 -4.2%
206.61
US$718,383 		3,477 -4.2% 206.61 US$718,383
2022-09-09 2022-09-07 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
2,629 -3.0%
205.88
US$541,259 		2,629 -3.0% 205.88 US$541,259
2022-09-09 2022-09-07 S Sale
2.3
Krasner Andrew Jay

Chief Financial Officer

Officer
1,030 -32.1%
210.26
US$216,570 		1,030 -32.1% 210.26 US$216,570
2022-09-06 2022-09-02 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,400 -1.5%
210.00
US$294,003 		1,400 -1.5% 210.00 US$294,003
2022-08-30 2022-08-26 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
10,000 -12.1%
209.47
US$2,094,700 		10,000 -12.1% 209.47 US$2,094,700
2022-08-22 2022-08-18 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
22,487 -23.7%
220.00
US$4,947,140 		22,487 -23.7% 220.00 US$4,947,140
2022-08-18 2022-08-17 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
398 -0.5%
220.00
US$87,560 		398 -0.5% 220.00 US$87,560
2022-08-18 2022-08-16 S Sale
2.2
WICKES GENE H

Head of Benefits Deliv & Admin

Officer
1,100 -1.5%
220.02
US$242,018 		1,100 -1.5% 220.02 US$242,018
2022-08-05 2022-08-04 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,400 -1.5%
210.01
US$294,014 		1,400 -1.5% 210.01 US$294,014
2022-06-02 2022-06-01 PlS Planned sale
3.1
Gebauer Julie Jarecke

Head of Health, Wealth &Career

Officer
1,400 -1.4%
210.67
US$294,938 		1,400 -1.4% 210.67 US$294,938
2022-11-02 2022-05-02 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
97 -0.7%
215.98
US$20,950 		97 -0.7% 215.98 US$20,950
2022-11-02 2022-05-02 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
300 -2.2%
214.50
US$64,350 		300 -2.2% 214.50 US$64,350
2022-11-02 2022-05-02 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
403 -2.8%
213.62
US$86,088 		403 -2.8% 213.62 US$86,088
2022-11-02 2022-05-02 PlS Planned sale
Bodnar Anne Donovan

Chief Administrative Officer

Officer
1,200 -7.8%
212.30
US$254,755 		1,200 -7.8% 212.30 US$254,755
Explore more

More insider trading research around Willis Towers Watson PLC

More insider trades in IE
Similar Financials companies with insider activity
More Insurance companies with insider activity
More Insurance companies with insider activity
Insider trades in S&P 500